Levodopa, the gold-standard treatment for Parkinson’s disease, is often given alongside medicines called catechol-O-methyltransferase inhibitors (COMT-Is) that are designed to boost its efficacy — but a new study suggests these medications may also reduce the amount of levodopa available to reach the brain. Specifically, the data suggest treatment with…
News
A new support group called Angels Embrace aims to offer education, connection, and emotional support for people affected by neurodegenerative conditions such as Parkinson’s disease and dementia. The program is being offered by Angels on Call Homecare, a company recognized for providing specialized Parkinson’s and dementia care at…
A small, lab-made molecule called SK-129 reduced the formation of toxic clumps of the alpha-synuclein protein, a hallmark of Parkinson’s disease, a study found. SK-129 was able to cross the blood-brain barrier – a semipermeable membrane that protects the brain and central nervous system – and prevent damage caused…
In the U.S., the total cost of Parkinson’s disease — including direct medical costs and lost productivity from patients and caregivers — was more than $82 billion in 2024, according to a new report from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The findings build on…
Scientists have demonstrated that it is possible to collect individualized data on how connections among brain circuits change for people with Parkinson’s disease who are undergoing deep brain stimulation (DBS) as a treatment for their symptoms. These findings lay the groundwork for more individualized approaches for DBS, and…
Fecal transplant — a procedure in which stool from healthy donors is transferred into a patient’s gut to restore a more normal bacterial balance — safely eased motor symptoms and constipation in adults with early, untreated Parkinson’s disease, according to a study. These patients also reported improvements in quality…
The Parkinson’s Foundation‘s largest annual fundraiser — Moving Day, A Walk for Parkinson’s — is marking its 15th anniversary, and the U.S.-based nonprofit has announced dates for a series of walks across the nation that aim to generate funding that will advance research and support care for people with…
April will be an activity-filled month for people living with Parkinson’s disease — and for doctors, researchers, and advocates — as the world recognizes Parkinson’s Awareness Month and World Parkinson’s Day on April 11. “For most people and their families, a Parkinson’s diagnosis is difficult…
Scientists in Denmark are embarking on a three-year project aiming to develop a Parkinson’s disease treatment that blocks the spread of toxic alpha-synuclein protein in the brain. “This breakthrough project positions Denmark at the forefront of Parkinson’s disease research, with a…
The first few participants in a clinical trial have reported notable easing of motor symptoms following treatment with Oryon Cell Therapies’Â Parkinson’s disease therapy, according to data released by the company. Data also indicate that Oryon’s therapy, which aims to replace lost brain cells with new nerve cells engineered…
Recent Posts
- When it comes to induction stoves, it’s better safe than sorry for me
- Parkinson’s medications may interact through gut bacteria, new study finds
- New support group offers help, connection for Parkinson’s families
- Looking back at the changing roles and relationships in Parkinson’s
- Lab-made small molecule may help slow brain disease progression